nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxamine—Metaraminol—Phenylpropanolamine—obesity	0.283	0.573	CrCrCtD
Methoxamine—Levonordefrin—Phenylpropanolamine—obesity	0.211	0.427	CrCrCtD
Methoxamine—ADRA1B—Phendimetrazine—obesity	0.144	0.338	CbGbCtD
Methoxamine—ADRA1A—Phendimetrazine—obesity	0.114	0.267	CbGbCtD
Methoxamine—ADRA1A—Benzphetamine—obesity	0.0864	0.202	CbGbCtD
Methoxamine—ADRA1A—Phenylpropanolamine—obesity	0.0824	0.193	CbGbCtD
Methoxamine—ADRA1B—Signaling by GPCR—AGT—obesity	9.83e-06	0.000125	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APOC3—obesity	9.81e-06	0.000125	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IAPP—obesity	9.81e-06	0.000125	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—STK11—obesity	9.79e-06	0.000124	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CCL2—obesity	9.75e-06	0.000124	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NTRK2—obesity	9.7e-06	0.000123	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PLG—obesity	9.68e-06	0.000123	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—RHOA—obesity	9.67e-06	0.000123	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ADRB1—obesity	9.66e-06	0.000123	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—AGT—obesity	9.61e-06	0.000122	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—AKT2—obesity	9.58e-06	0.000122	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—PIK3R1—obesity	9.57e-06	0.000122	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PIK3CG—obesity	9.57e-06	0.000122	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HTR1B—obesity	9.53e-06	0.000121	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CRH—obesity	9.53e-06	0.000121	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GHRL—obesity	9.45e-06	0.00012	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PARP1—obesity	9.45e-06	0.00012	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—FOXO3—obesity	9.45e-06	0.00012	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ADRB2—obesity	9.43e-06	0.00012	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SDC1—obesity	9.42e-06	0.00012	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PRKCD—obesity	9.4e-06	0.000119	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—DRD4—obesity	9.38e-06	0.000119	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—SOCS1—obesity	9.28e-06	0.000118	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AKR1C3—obesity	9.27e-06	0.000118	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PIK3CD—obesity	9.2e-06	0.000117	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—HTR2A—obesity	9.2e-06	0.000117	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—C3—obesity	9.18e-06	0.000117	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—SOCS3—obesity	9.17e-06	0.000117	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—POMC—obesity	9.11e-06	0.000116	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PRKCB—obesity	9.08e-06	0.000115	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—F2—obesity	9.08e-06	0.000115	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NPS—obesity	9.03e-06	0.000115	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—GNB3—obesity	8.98e-06	0.000114	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CNR1—obesity	8.95e-06	0.000114	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PRKCB—obesity	8.88e-06	0.000113	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—F2—obesity	8.88e-06	0.000113	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HTR2C—obesity	8.86e-06	0.000113	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—DRD1—obesity	8.86e-06	0.000113	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—TYK2—obesity	8.85e-06	0.000113	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—PIK3CB—obesity	8.83e-06	0.000112	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IGF2—obesity	8.82e-06	0.000112	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TCF7L2—obesity	8.79e-06	0.000112	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—RHOA—obesity	8.78e-06	0.000112	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—AKT2—obesity	8.75e-06	0.000111	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—GNAS—obesity	8.74e-06	0.000111	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—DRD2—obesity	8.73e-06	0.000111	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—AGT—obesity	8.73e-06	0.000111	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PIK3R1—obesity	8.69e-06	0.00011	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3CG—obesity	8.69e-06	0.00011	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PTPN1—obesity	8.65e-06	0.00011	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GCG—obesity	8.65e-06	0.00011	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NTRK2—obesity	8.62e-06	0.000109	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ADRB1—obesity	8.58e-06	0.000109	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—APOB—obesity	8.56e-06	0.000109	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3CG—obesity	8.5e-06	0.000108	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PIK3CD—obesity	8.41e-06	0.000107	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GHRL—obesity	8.4e-06	0.000107	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PARP1—obesity	8.4e-06	0.000107	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CCL5—obesity	8.36e-06	0.000106	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—DRD4—obesity	8.33e-06	0.000106	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—POMC—obesity	8.27e-06	0.000105	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PRL—obesity	8.25e-06	0.000105	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—LPL—obesity	8.17e-06	0.000104	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—STK11—obesity	8.13e-06	0.000103	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—FOXO1—obesity	8.12e-06	0.000103	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—RPS6KB1—obesity	8.1e-06	0.000103	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CCL2—obesity	8.09e-06	0.000103	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—POMC—obesity	8.09e-06	0.000103	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—F2—obesity	8.06e-06	0.000102	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PRKCB—obesity	8.06e-06	0.000102	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PLG—obesity	8.04e-06	0.000102	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—RHOA—obesity	8.02e-06	0.000102	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PIK3CB—obesity	8.02e-06	0.000102	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CNR1—obesity	7.95e-06	0.000101	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—AKT2—obesity	7.95e-06	0.000101	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PIK3R1—obesity	7.94e-06	0.000101	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FOXO3—obesity	7.85e-06	9.97e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ADRB2—obesity	7.82e-06	9.94e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TCF7L2—obesity	7.81e-06	9.93e-05	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—AKT2—obesity	7.78e-06	9.88e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—DRD2—obesity	7.76e-06	9.86e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CG—obesity	7.72e-06	9.81e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—SOCS1—obesity	7.71e-06	9.79e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PTPN1—obesity	7.68e-06	9.76e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GCG—obesity	7.68e-06	9.76e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3CD—obesity	7.64e-06	9.71e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—SOCS3—obesity	7.61e-06	9.67e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PRKCD—obesity	7.53e-06	9.57e-05	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3CD—obesity	7.47e-06	9.49e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GNB3—obesity	7.45e-06	9.47e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HTR2A—obesity	7.37e-06	9.37e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—C3—obesity	7.36e-06	9.35e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—TYK2—obesity	7.35e-06	9.34e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—POMC—obesity	7.35e-06	9.34e-05	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PIK3CB—obesity	7.33e-06	9.32e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PRL—obesity	7.33e-06	9.31e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IGF2—obesity	7.32e-06	9.3e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—RHOA—obesity	7.29e-06	9.26e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GNAS—obesity	7.26e-06	9.22e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—STK11—obesity	7.22e-06	9.18e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3R1—obesity	7.21e-06	9.17e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CCL2—obesity	7.19e-06	9.13e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PLG—obesity	7.14e-06	9.07e-05	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—RHOA—obesity	7.13e-06	9.06e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—APOB—obesity	7.11e-06	9.03e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—AKT2—obesity	7.06e-06	8.97e-05	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3R1—obesity	7.05e-06	8.97e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IRS2—obesity	7e-06	8.9e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—AGT—obesity	6.99e-06	8.89e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FOXO3—obesity	6.97e-06	8.86e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ADRB2—obesity	6.95e-06	8.83e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CCL5—obesity	6.94e-06	8.82e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—LEP—obesity	6.85e-06	8.71e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—APOE—obesity	6.85e-06	8.71e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SOCS1—obesity	6.84e-06	8.7e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CAV1—obesity	6.79e-06	8.63e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—LPL—obesity	6.78e-06	8.62e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CD—obesity	6.78e-06	8.62e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—APOA1—obesity	6.77e-06	8.61e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SOCS3—obesity	6.76e-06	8.59e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FOXO1—obesity	6.74e-06	8.56e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—RPS6KB1—obesity	6.72e-06	8.54e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3CB—obesity	6.66e-06	8.46e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GNB3—obesity	6.62e-06	8.41e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ESR1—obesity	6.54e-06	8.31e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—TYK2—obesity	6.53e-06	8.29e-05	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3CB—obesity	6.51e-06	8.28e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IGF2—obesity	6.5e-06	8.26e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—RHOA—obesity	6.47e-06	8.23e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—F2—obesity	6.46e-06	8.21e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PRKCB—obesity	6.46e-06	8.21e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GNAS—obesity	6.44e-06	8.19e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3R1—obesity	6.41e-06	8.14e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—BAD—obesity	6.38e-06	8.11e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APOB—obesity	6.31e-06	8.02e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PRKCD—obesity	6.25e-06	7.94e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CG—obesity	6.18e-06	7.86e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CCL5—obesity	6.16e-06	7.83e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HTR2A—obesity	6.12e-06	7.77e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IRS1—obesity	6.11e-06	7.77e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—C3—obesity	6.11e-06	7.76e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—LPL—obesity	6.03e-06	7.66e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FOXO1—obesity	5.98e-06	7.6e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—RPS6KB1—obesity	5.97e-06	7.59e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CB—obesity	5.91e-06	7.51e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—POMC—obesity	5.89e-06	7.48e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—INS—obesity	5.85e-06	7.44e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IRS2—obesity	5.81e-06	7.39e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—AGT—obesity	5.8e-06	7.38e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CCL2—obesity	5.76e-06	7.32e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—LEP—obesity	5.69e-06	7.23e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—APOE—obesity	5.69e-06	7.23e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IGF1—obesity	5.66e-06	7.2e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—AKT2—obesity	5.66e-06	7.19e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CAV1—obesity	5.63e-06	7.16e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—APOA1—obesity	5.62e-06	7.14e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PRKCD—obesity	5.55e-06	7.06e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CD—obesity	5.44e-06	6.91e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HTR2A—obesity	5.43e-06	6.91e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ESR1—obesity	5.43e-06	6.9e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—C3—obesity	5.43e-06	6.9e-05	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—PIK3CA—obesity	5.38e-06	6.84e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—SERPINE1—obesity	5.38e-06	6.83e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—F2—obesity	5.36e-06	6.82e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PRKCB—obesity	5.36e-06	6.82e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—BAD—obesity	5.3e-06	6.73e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TYK2—obesity	5.23e-06	6.65e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—RHOA—obesity	5.19e-06	6.59e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IRS2—obesity	5.16e-06	6.56e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AGT—obesity	5.16e-06	6.55e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3R1—obesity	5.13e-06	6.52e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NOS3—obesity	5.13e-06	6.52e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CG—obesity	5.13e-06	6.52e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IRS1—obesity	5.07e-06	6.45e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APOE—obesity	5.05e-06	6.42e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—LEP—obesity	5.05e-06	6.42e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CAV1—obesity	5e-06	6.36e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APOA1—obesity	4.99e-06	6.35e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PIK3CA—obesity	4.89e-06	6.21e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—POMC—obesity	4.89e-06	6.21e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—INS—obesity	4.86e-06	6.17e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ESR1—obesity	4.82e-06	6.13e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CCL2—obesity	4.78e-06	6.07e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—F2—obesity	4.76e-06	6.05e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PRKCB—obesity	4.76e-06	6.05e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CB—obesity	4.74e-06	6.02e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MTOR—obesity	4.74e-06	6.02e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—BAD—obesity	4.71e-06	5.98e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IGF1—obesity	4.7e-06	5.97e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—AKT2—obesity	4.7e-06	5.97e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CG—obesity	4.56e-06	5.79e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CD—obesity	4.51e-06	5.73e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IRS1—obesity	4.51e-06	5.73e-05	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PIK3CA—obesity	4.47e-06	5.68e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—SERPINE1—obesity	4.46e-06	5.67e-05	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—AKT1—obesity	4.4e-06	5.59e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TYK2—obesity	4.34e-06	5.52e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—POMC—obesity	4.34e-06	5.51e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—IL6—obesity	4.33e-06	5.5e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—INS—obesity	4.32e-06	5.48e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—RHOA—obesity	4.3e-06	5.47e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NOS3—obesity	4.26e-06	5.41e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3R1—obesity	4.26e-06	5.41e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CCL2—obesity	4.25e-06	5.4e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IGF1—obesity	4.17e-06	5.3e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AKT2—obesity	4.17e-06	5.3e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MMP9—obesity	4.12e-06	5.23e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3CA—obesity	4.06e-06	5.16e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CD—obesity	4.01e-06	5.09e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MAPK8—obesity	4.01e-06	5.09e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—AKT1—obesity	3.99e-06	5.08e-05	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	3.97e-06	5.04e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SERPINE1—obesity	3.96e-06	5.04e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MTOR—obesity	3.93e-06	5e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CB—obesity	3.93e-06	5e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TYK2—obesity	3.86e-06	4.9e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—RHOA—obesity	3.82e-06	4.86e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NOS3—obesity	3.78e-06	4.81e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3R1—obesity	3.78e-06	4.81e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—STAT3—obesity	3.66e-06	4.65e-05	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—AKT1—obesity	3.65e-06	4.64e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CA—obesity	3.6e-06	4.58e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—IL6—obesity	3.59e-06	4.57e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MTOR—obesity	3.49e-06	4.44e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CB—obesity	3.49e-06	4.44e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MMP9—obesity	3.42e-06	4.34e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MYC—obesity	3.4e-06	4.32e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TGFB1—obesity	3.39e-06	4.31e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MAPK8—obesity	3.32e-06	4.22e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—AKT1—obesity	3.32e-06	4.21e-05	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—AKT1—obesity	3.24e-06	4.12e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—IL6—obesity	3.19e-06	4.06e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—STAT3—obesity	3.04e-06	3.86e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MMP9—obesity	3.04e-06	3.86e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MAPK8—obesity	2.95e-06	3.75e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—AKT1—obesity	2.94e-06	3.74e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CA—obesity	2.89e-06	3.67e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MYC—obesity	2.82e-06	3.59e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TGFB1—obesity	2.82e-06	3.58e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—STAT3—obesity	2.7e-06	3.43e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IL6—obesity	2.56e-06	3.25e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MYC—obesity	2.51e-06	3.19e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TGFB1—obesity	2.5e-06	3.18e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CA—obesity	2.4e-06	3.05e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—AKT1—obesity	2.36e-06	3e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CA—obesity	2.13e-06	2.71e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IL6—obesity	2.12e-06	2.7e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—AKT1—obesity	1.96e-06	2.49e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL6—obesity	1.89e-06	2.4e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AKT1—obesity	1.74e-06	2.21e-05	CbGpPWpGaD
